A British pharmaceutical company faces three major milestones over the next three months that Bernstein says could strengthen the case ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE